AstraZeneca Competitors

AZN Stock  USD 67.75  0.51  0.75%   
AstraZeneca PLC ADR competes with Chevron Corp, McDonalds, Bank of America, Alcoa Corp, and Coca Cola; as well as few others. The company runs under Pharmaceuticals sector within Health Care industry. Analyzing AstraZeneca PLC competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AstraZeneca PLC to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out AstraZeneca PLC Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AstraZeneca PLC competition on your existing holdings.
  
As of the 29th of March 2024, Return On Assets is likely to grow to 0.10, while Return On Capital Employed is likely to drop 0.11. At this time, AstraZeneca PLC's Asset Turnover is very stable compared to the past year.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
66.4267.7369.04
Details
Intrinsic
Valuation
LowRealHigh
60.9874.8776.18
Details
Naive
Forecast
LowNextHigh
65.4566.7568.06
Details
13 Analysts
Consensus
LowTargetHigh
76.1883.7192.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AstraZeneca PLC. Your research has to be compared to or analyzed against AstraZeneca PLC's peers to derive any actionable benefits. When done correctly, AstraZeneca PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AstraZeneca PLC ADR.

AstraZeneca PLC Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AstraZeneca PLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of AstraZeneca and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AstraZeneca PLC ADR does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
XOMBAC
IBMWMT
XOMWMT
XOMCVX
WMTBAC
WMTCVX
  
High negative correlations   
XOMMCD
BACMCD
MCDCVX
WMTMCD
KOMCD
IBMMCD

Risk-Adjusted Indicators

There is a big difference between AstraZeneca Stock performing well and AstraZeneca PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AstraZeneca PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare AstraZeneca PLC ADR and related stocks such as Chevron Corp, McDonalds, and Bank Of America Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
CVX1.6 B26.9 B26.2 B21.4 B19.2 B4.6 B(497 M)9.2 B14.8 B2.9 B(5.6 B)15.6 B35.5 B21.4 B11.3 B
MCD433 M5.5 B5.5 B5.6 B4.8 B4.5 B4.7 B5.2 B5.9 BB4.7 B7.5 B6.2 B8.5 B8.9 B
BAC1.1 B1.4 B2.8 B9.2 B4.5 B14.4 B16.1 B16.6 B26.7 B27.4 B17.9 B32 B27.5 B26.5 B27.8 B
AA(2.9 B)(2.9 B)(2.9 B)(2.9 B)(256 M)(863 M)(400 M)217 M227 M(853 M)(14 M)429 M59 M(651 M)(683.5 M)
KO722.3 M8.6 BB8.6 B7.1 B7.4 B6.5 B1.2 B6.4 B8.9 B7.7 B9.8 B9.5 B10.7 B5.4 B
WMT327.5 M15.7 B17 B16 B16.4 B14.7 B13.6 B9.9 B6.7 B14.9 B13.5 B13.7 B11.7 B15.5 B9.3 B
IBM6.6 B15.9 B16.6 B16.5 B12 B13.2 B11.9 B5.8 B8.7 B9.4 B5.6 B5.7 B1.6 B7.5 BB
XOM4.9 B41.1 B44.9 B32.6 B32.5 B16.1 B7.8 B19.7 B20.8 B14.3 B(22.4 B)23 B55.7 B36 B20.1 B

AstraZeneca PLC ADR and related stocks such as Chevron Corp, McDonalds, and Bank Of America Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in AstraZeneca PLC ADR financial statement analysis. It represents the amount of money remaining after all of AstraZeneca PLC ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

AstraZeneca PLC Competitive Analysis

The better you understand AstraZeneca PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AstraZeneca PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AstraZeneca PLC's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AZNCVXMCDBACAAKOWMTIBMXOM
 0.75 
 67.75 
AstraZeneca
 0.89 
 157.74 
Chevron
 0.02 
 281.95 
McDonalds
 0.29 
 37.92 
Bank
 1.75 
 33.79 
Alcoa
 0.25 
 61.18 
Coca
 0.91 
 60.17 
Walmart
 0.08 
 190.96 
International
 1.10 
 116.24 
Exxon
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

AstraZeneca PLC Competition Performance Charts

Five steps to successful analysis of AstraZeneca PLC Competition

AstraZeneca PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AstraZeneca PLC ADR in relation to its competition. AstraZeneca PLC's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AstraZeneca PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AstraZeneca PLC's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AstraZeneca PLC ADR, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AstraZeneca PLC position

In addition to having AstraZeneca PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Funds Thematic Idea Now

Consumer Funds
Consumer Funds Theme
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out AstraZeneca PLC Correlation with its peers.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.